357 related articles for article (PubMed ID: 26558364)
1. Metamorphic thyroid autoimmunity in Down Syndrome: from Hashimoto's thyroiditis to Graves' disease and beyond.
Aversa T; Valenzise M; Salerno M; Corrias A; Iughetti L; Radetti G; De Luca F; Wasniewska M
Ital J Pediatr; 2015 Nov; 41():87. PubMed ID: 26558364
[TBL] [Abstract][Full Text] [Related]
2. In young patients with Turner or Down syndrome, Graves' disease presentation is often preceded by Hashimoto's thyroiditis.
Aversa T; Lombardo F; Corrias A; Salerno M; De Luca F; Wasniewska M
Thyroid; 2014 Apr; 24(4):744-7. PubMed ID: 24325626
[TBL] [Abstract][Full Text] [Related]
3. Persistent remission of Graves` disease or evolution from Graves' disease to Hashimoto's thyroiditis in childhood - a report of 6 cases and clinical implications.
Smyczńyska J; Cyniak-Magierska A; Stasiak M; Karbownik-Lewińska M; Lewiński A
Neuro Endocrinol Lett; 2014; 35(5):335-41. PubMed ID: 25275265
[TBL] [Abstract][Full Text] [Related]
4. Peculiarities of Graves' disease in children and adolescents with Down's syndrome.
De Luca F; Corrias A; Salerno M; Wasniewska M; Gastaldi R; Cassio A; Mussa A; Aversa T; Radetti G; Arrigo T
Eur J Endocrinol; 2010 Mar; 162(3):591-5. PubMed ID: 19955260
[TBL] [Abstract][Full Text] [Related]
5. Frequency of Hashimoto's thyroiditis antecedents in the history of children and adolescents with graves' disease.
Wasniewska M; Corrias A; Arrigo T; Lombardo F; Salerno M; Mussa A; Vigone MC; De Luca F
Horm Res Paediatr; 2010; 73(6):473-6. PubMed ID: 20395669
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune Thyroiditis Shifting from Hashimoto's Thyroiditis to Graves' Disease.
Daramjav N; Takagi J; Iwayama H; Uchino K; Inukai D; Otake K; Ogawa T; Takami A
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109715
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of primary hyperthyroidism caused by Graves' disease admixed with resistance to thyroid hormone (P453T).
Sato H
Endocr J; 2010; 57(8):687-92. PubMed ID: 20574139
[TBL] [Abstract][Full Text] [Related]
8. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
[TBL] [Abstract][Full Text] [Related]
9. Peculiarities of autoimmune thyroid diseases in children with Turner or Down syndrome: an overview.
Aversa T; Lombardo F; Valenzise M; Messina MF; Sferlazzas C; Salzano G; De Luca F; Wasniewska M
Ital J Pediatr; 2015 May; 41():39. PubMed ID: 25971674
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum IL-16 and RANTES levels in patients with autoimmune thyroid diseases and modulation by methimazole therapy.
Gu X; Zheng L; Chen X; Ruan L; Zhang H; Ge S; Zhu H; Lin X; Shen F
Horm Metab Res; 2012 Jun; 44(6):482-7. PubMed ID: 22473756
[TBL] [Abstract][Full Text] [Related]
11. Changes of IgG
Trzos S; Link-Lenczowski P; Sokołowski G; Pocheć E
Front Immunol; 2022; 13():841710. PubMed ID: 35370997
[TBL] [Abstract][Full Text] [Related]
12. 25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient.
Ke W; Sun T; Zhang Y; He L; Wu Q; Liu J; Zha B
Endocr J; 2017 Jun; 64(6):581-587. PubMed ID: 28413173
[TBL] [Abstract][Full Text] [Related]
13. Atypical phenotypic aspects of autoimmune thyroid disorders in young patients with Turner syndrome.
Aversa T; Gallizzi R; Salzano G; Zirilli G; De Luca F; Valenzise M
Ital J Pediatr; 2018 Jan; 44(1):12. PubMed ID: 29343299
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of long-term follow-up and methimazole therapy outcomes of pediatric Graves' disease: a single-center experience.
Bayramoğlu E; Elmaogulları S; Sagsak E; Aycan Z
J Pediatr Endocrinol Metab; 2019 Apr; 32(4):341-346. PubMed ID: 30862763
[TBL] [Abstract][Full Text] [Related]
15. Four cases of Graves' disease which developed after painful Hashimoto's thyroiditis.
Ohye H; Nishihara E; Sasaki I; Kubota S; Fukata S; Amino N; Kuma K; Miyauchi A
Intern Med; 2006; 45(6):385-9. PubMed ID: 16617190
[TBL] [Abstract][Full Text] [Related]
16. Peculiarities of presentation and evolution over time of Hashimoto's thyroiditis in children and adolescents with Down's syndrome.
Aversa T; Salerno M; Radetti G; Faienza MF; Iughetti L; Corrias A; Predieri B; Mussa A; Mirabelli S; De Luca F; Wasniewska M
Hormones (Athens); 2015; 14(3):410-6. PubMed ID: 26188225
[TBL] [Abstract][Full Text] [Related]
17. Hashimoto's thyroiditis following Graves' disease.
Umar H; Muallima N; Adam JM; Sanusi H
Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330
[TBL] [Abstract][Full Text] [Related]
18. Antithyroid drug treatment for graves' disease in children: a long-term retrospective study at a single institution.
Ohye H; Minagawa A; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Suzuki M; Yoshihara A; Ito K; Ito K
Thyroid; 2014 Feb; 24(2):200-7. PubMed ID: 23926918
[TBL] [Abstract][Full Text] [Related]
19. "Block-and-replace" treatment in Graves' disease: experience in a cohort of pediatric patients.
Vigone MC; Peroni E; Di Frenna M; Mora S; Barera G; Weber G
J Endocrinol Invest; 2020 May; 43(5):595-600. PubMed ID: 31713721
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
